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Hypothermia is the most effective means of protecting the brain, heart and other organs during
ischemia/reperfusion (I/R) injury. However, the precise mechanisms for hypothermia to inhibit
I/R-induced endothelial cell apoptosis are not fully understood. In the present study, human
umbilical endothelial cells (HUVECs) were exposed to ischemia followed by reperfusion under nor-
mothermia (37 C) or hypothermia (33 C). Our results showed that hypothermia markedly reduced
I/R-induced endothelial cell apoptosis, the expression of cleaved caspase-3 and PARP. Moreover,
hypothermia markedly reversed I/R-induced activation of Fas/caspase-8, the increase of Bax and
decrease of Bcl-2. Furthermore, hypothermia inhibited JNK1/2 activation via MKP-1 induction.
Together, these data demonstrate that hypothermia represses I/R-induced endothelial cell apoptosis
by inhibiting both extrinsic- and intrinsic-dependent apoptotic pathways and activation of JNK1/2.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Vascular endothelial cells are involved in many aspects of vas-
cular biology, including vasodilation, blood clotting, angiogenesis,
inﬂammation and barrier function. Exposure of endothelial mono-
layer to ischemia/reperfusion (I/R) may lead to endothelial cell in-
jury and dysfunction, which play a crucial role in the initiation and
progression of various diseases [1]. Numerous studies demonstrate
that endothelial cells appear to be one of the primary targets for I/R
injury [1]. This stress leads to dysfunction of vascular endothelial
cells, thereby stimulating cellular calcium overload, generation of
reactive oxygen-derived species (ROS), and release of cytokines
that may further initiate the apoptotic program and necrosis in
endothelial cells [2,3]. Although necrosis represents the classic
manifestation of ischemia-induced cell damage, apoptosis appears
to be an early event during I/R injury [2,3]. Recent studies have
demonstrated that both the mitochondrial (intrinsic) and the death
receptor (extrinsic) pathways of caspase activation are triggered
during I/R leading to endothelial cell apoptosis.
The pathogenesis of endothelial I/R injury involves the interplay
of multiple mechanisms. Several studies demonstrate that several
cell survival and apoptotic pathways including the mitogen-acti-
vated protein kinases (MAPKs) play an important role in thechemical Societies. Published by E
his work.induction of apoptosis following I/R injury [2,3]. MAPKs include
extracellular signal-regulated kinase 1/2 (ERK1/2), c-JunN-terminal
protein kinase 1/2 (JNK1/2), and p38 MAPK, which are major medi-
ators of intracellular signals in response to various stimuli. Earlier
studies demonstrated that the activation of ERK1/2 after reperfu-
sion is cardioprotective [2,3], whereas activation of JNK1/2 and
p38 MAPK has shown to correlate well with the apoptosis induced
by I/R injury [2,3]. Furthermore, studies using the inhibitors have
suggested that activation of JNK1/2 and/or p38 MAPK is necessary
for I/R-induced apoptosis in endothelial cells and cardiac myocytes
[4,5].
Therapeutic hypothermia is a new treatment which increases
survival chances and quality for patients suffering from ischemic
insults such as cardiac arrest, stroke, and neurogenic fever follow-
ing brain trauma [6–8]. The earliest explanations for why hypo-
thermia acted as an effective method focused on the slowing of
cellular metabolism resulted from a drop in body temperature
[8,9]. Recently, one of the most promising mechanisms centers
the apoptotic and inﬂammatory response following I/R injury
[10]. Several studies demonstrate that hypothermia can inhibit
I/R-induced oxidative stress and apoptosis through enhancing the
expression of anti-apoptotic Bcl-x and repressing the expression
of p53 in rat cardiomyocytes [11,12]. However, it is still unclear
which molecules or signaling pathways are involved in the biolog-
ical action of hypothermia, especially in vascular endothelial
protection after I/R injury. In the present study, we have investi-
gated the protective role of hypothermia in I/R-induced endotheliallsevier B.V. All rights reserved.
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Fig. 1. Hypothermia inhibits I/R-induced apoptosis in HUVECs. (A) HUVECs were
subjected to ischemia followed by normothermic or hypothermic reperfusion for
indicated time points. Cell apoptosis was determined by TUNEL assay. A represen-
tative ﬁeld was shown for each condition at 6 h of reperfusion (magniﬁcation,
200). (B) The number of TUNEL-positive cells was quantiﬁed, and at least 120 cells
per dish were counted (n = 5, means ± S.E.M.). *P < 0.05 vs. control cells, #P < 0.05 vs.
normothermic cells. N: normothermia; H: hypothermia.
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markedly attenuated I/R-induced endothelial cell apoptosis by reg-
ulating extrinsic- and intrinsic-dependent apoptotic pathways and
JNK1/2 activation.
2. Materials and methods
2.1. Antibodies and reagents
Anti-cleaved caspase-3 (#9661), anti-cleaved PARP (#9541),
anti-Fas (#4233), anti-cleaved caspase-8 (#9496), anti-Bax
(#2772), anti-Bcl-2 (#2876), anti-phospho-JNK1/2 (#9251), anti-
JNK1/2 (#9252), anti-phospho-MKK4 (#9151), anti-MKK4
(#9152), anti-GAPDH (#2118), and horseradish peroxidase-conju-
gated secondary antibodies were purchased from Cell Signaling
Technology. Anti-MKP-1 (sc-370) antibody was obtained from San-
ta Cruz Biotechnology. SP600125 was obtained from Calbiochem.
All other chemicals were purchased from Sigma.
2.2. Cell culture
Human umbilical endothelial cells (HUVECs) were cultured in
endothelial cell medium (ECM) supplemented with endothelial cell
growth supplement (ECGS), 5% fetal bovine serum (FBS) and peni-
cillin/streptomycin (P/S) solution (Sciencell) in an incubator with
37 C, 5% CO2. For experiments, cells of passage no. 4–6 were
grown until conﬂuence. In some experiments, HUVECs were pre-
treated with SP600125 (JNK-speciﬁc inhibitor, 20 lM) for 30 min
and then subjected to the ischemia/reperfusion (I/R) protocol.
2.3. Ischemia/reperfusion (I/R) experimental protocol
HUVECs were subjected to oxygen–glucose deprivation (OGD)
injury [13,14]. The OGD injury was initiated by placing cells in a
tri-gas incubator with an atmosphere of 37 C, 5% CO2, 94% N2
and 1% O2 and in the presence of OGD media for 5 h. After that,
the exposure medium was exchanged with oxygenated ECM, and
the cells were placed in an incubator at 37 C (normothermia) or
33 C (hypothermia) to mimic the reperfusion condition for 0–20 h.
2.4. Evaluation of cell apoptosis
Apoptosis was analyzed with In situ Cell Death Detection Kit,
POD (Roche) according to manufacturer’s instructions. Cells were
examined by light microscopy. The number of TUNEL-positive cells
was analyzed using NIH Image software [14].
2.5. siRNA experiments
MKP-1 siRNA (siMKP-1) and non-targeting siRNA (siNT) were
obtained from Dharmacon Inc. A non-targeting siRNA was used
as a control for non-sequence-speciﬁc effects of the transfected
siRNAs. siRNAs were transfected with DharmaFECT1 (Dharmacon)
into HUVECs following the manufacture’s protocol.
2.6. Western blot analysis
Immunoblotting was performed according to the previous pro-
tocols [15]. Total proteins were extracted from HUVECs using cell
lysis buffer. Protein (40–60 lg) from each sample were separated
by SDS–PAGE, transferred to nitrocellulose membranes, and
probed with primary antibodies and then with horseradish perox-
idase-conjugated secondary antibodies. The enhanced chemilumi-
nescence signal was quantiﬁed using a densitometry program
(Gel-pro 4.5 Analyzer, Media Cybernetics). To quantify the proteinsignal, we subtracted background, normalized the value to GAPDH.
As for the phospho-speciﬁc protein, we normalized the signal to
the amount of total target protein and GAPDH.
2.7. Statistical analysis
All results are presented as means ± S.E.M. Differences between
groups were evaluated for statistical signiﬁcance using Student’s t
or ANOVA tests. In each case, signiﬁcance was deﬁned as P < 0.05.
3. Results
3.1. Hypothermia attenuates the I/R-induced endothelial apoptosis
To investigate the protective role of hypothermia in I/R-induced
endothelial cell function, we ﬁrst examined the effect of hypother-
mia on I/R-induced apoptosis. As shown in Fig. 1A and B, treatment
of HUVECs with I/R signiﬁcantly increased apoptosis as determined
by TUNEL assay under normothermia, whereas hypothermia mark-
edly suppressed the action of I/R injury on HUVECs after 6 h of
reperfusion.
3.2. Hypothermia inhibits I/R-induced expression of cleaved caspase-3
and PARP
We next examine whether the protective effect of hypothermia
was mediated by attenuating expression of cleaved caspase-3 and
PARP, and the cleaved protein levels in I/R-treated cells were ana-
lyzed by Western blot. As shown in Fig. 2A and B, the level of
cleaved caspase-3 and PARP was increased in I/R-treated cells at
2 h after reperfusion, peaked at 6 h, and sustained as long as 20 h
compared with control under normal temperature. However,
hypothermia treatment signiﬁcantly decreased the levels of
ACleaved 
caspase-3
Cleaved 
PARP
GAPDH
20 min 2 h 6 h 20 h
C
on
tro
l
N H N H N H N H Blot
0
1
2
3
4
5
6
B
8
10
 F
ol
ds
 v
er
su
s 
co
nt
ro
l
20 min 2 h 6 h 20 h
N H N H N H N H
9
7
C
on
tro
l
*
*
*
*
# #
#
#
Cleaved caspase-3
Cleaved PARP
Fig. 2. Hypothermia attenuates I/R-induced cleavage of procaspase-3 and PARP. (A)
HUVECs were subjected to ischemia followed by normothermic or hypothermic
reperfusion for indicated time points. The protein level of cleaved caspase-3 and
PARP was examined by immunoblotting. A representative blot was shown. (B)
Quantitative analysis of cleaved caspase-3 and PARP was expressed as fold increase
above control group (n = 3, mean ± S.E.M.). *P < 0.05 vs. control cells, #P < 0.05 vs.
normothermic cells. N: normothermia; H: hypothermia.
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after reperfusion compared with normothermia-treated cells.
3.3. Hypothermia represses expression of Fas and cleaved caspase-8
To test whether hypothermia regulates death receptor-medi-
ated pathway, we performed western blot analysis to detect the
expression of Fas and cleaved caspapse-8 after treatment with nor-
mothermia or hypothermia. As shown in Fig. 3A and B, the expres-
sion of Fas and cleaved caspase-8 was increased in I/R-treated cells
at 2 h of reperfusion, peaked at 6 h, sustained as long as 20 h com-
pared with control. Importantly, hypothermia treatment markedly
decreased the levels of Fas and cleaved caspase-8 compared with
normothermia-treated cells at 2 h, 6 h and 20 h after reperfusion.
3.4. Hypothermia regulates expression of Bcl-2 and Bax
To determine whether hypothermia alters mitochondrial-med-
iated pathway, the expression of anti-apoptotic Bcl-2 and pro-
apoptotic Bax was examined by Western blot in I/R-treated cells
under normothermia or hypothermia. Compared with normother-
mic cells, I/R resulted in an increase in Bax protein and a decrease
in Bcl-2 protein. These changes were attenuated in hypothermia-
treated cells (Fig. 4A and B). Furthermore, the increased Bax/Bcl-
2 ratio in HUVECs exposed to I/R was attenuated by hypothermia
compared with normothermic cells at 2 h and 6 h of reperfusion
(Fig. 4C).
3.5. Hypothermia attenuates I/R-induced activation of JNK1/2
Because JNK1/2 and p38 MAPK signaling pathways play an
important role in oxidative stress-induced apoptosis [4,5,16], weFas
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JNK1/2 and p38 MAPK in the I/R-treated cells byWestern blot anal-
ysis. As shown in Fig. 5A and B, hypothermia signiﬁcantly inhibited
I/R-induced JNK1/2 phosphorylation at 20 min and 6 h of reperfu-
sion compared with normothermia-treated cells. However,
hypothermia had no effect on p38 MAPK phosphorylation at all
the time points (data not shown).
3.6. Hypothermia inhibits I/R-induced apoptosis via inhibition of JNK1/
2
To examine whether hypothermia-mediated suppression of
JNK1/2 activity is required for the protection against I/R-induced
apoptosis, HUVECs were pretreated with JNK inhibitor SP600125.
As shown in Fig. 6A–C, I/R signiﬁcantly increased JNK1/2 phosphor-
ylation, expression of cleaved caspase-3 and PARP, and apoptotic
cells under normothermia compared with control (compared 4
with 1). In contrast, these effects induced by I/R were signiﬁcantly
attenuated by hypothermia (compared 5 with 4), indicating that
hypothermia can signiﬁcantly inhibit I/R-induced JNK1/2 activa-0
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Fig. 4. Hypothermia alters I/R-induced expression of Bcl-2 and Bax protein. (A) HUVECs
for indicated time points. The expression of Bax and Bcl-2 protein was analyzed by imm
Bcl-2 was expressed as fold increase above control group (n = 3, mean ± S.E.M.). (C) Quant
(n = 3, mean ± S.E.M.). *P < 0.05 vs. control cells, #P < 0.05 vs. normothermic cells. N: nortion and endothelial cell apoptosis. Moreover, SP600125 alone
completely abolished I/R-induced activation of JNK1/2, but only
partially inhibited the level of cleaved caspase-3 and PARP, and
subsequent apoptosis (compared 2 with 4). Furthermore, hypo-
thermia in combination with SP600125 completely inhibited I/R-
induced response compared with SP600125 plus normothermia
(compared 3 with 2), suggesting that hypothermia may inhibit I/
R-induced endothelial cell apoptosis through other mechanisms.
Taken together, these results indicate that the protective effect of
hypothermia is mediated in part via JNK pathway in HUVECs after
I/R injury.
3.7. Hypothermia attenuates activation of JNK1/2 via induction of
MKP-1
To determine the precise mechanism by which hypothermia
inhibited I/R-induced JNK activation, the potential action of hypo-
thermia on its upstream kinase MKK4 was examined. As shown in
Fig. 7A, hypothermia had no effect on I/R-induced activation of
MKK4 compared with normothermic cells at all time points.Bax
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2504 D. Yang et al. / FEBS Letters 583 (2009) 2500–2506Furthermore, treatment with hypothermia alone did not alter
MKK4 phosphorylation (data not shown), excluding the effect of
MKK4 on hypothermia-mediated inhibition of JNK1/2.
It has been reported that MKP-1 is a major negative regulator of
JNK [17], we therefore examined whether hypothermia induced
MKP-1 expression. As shown in Fig. 7A, hypothermia increased
MKP-1 protein level at all time points of reperfusion compared
with normothemia-treated cells. We also found that treatment
with hypothermia alone increased MKP-1 expression and de-
creased JNK1/2 phosphorylation in a time-dependent manner
(data not shown). To further determine the causal role of hypother-
mia in MKP-1 induction and JNK1/2 inactivation, siRNA knock-
down experiments were performed in HUVECs. siMKP-1
signiﬁcantly attenuated the inhibitory effect of hypothermia on
JNK1/2 phosphoryation and apoptosis, whereas siNT had no effect.
siMKP-1 did not affect total JNK1/2 (Fig. 7B and C). These ﬁndings
indicate that hypothermia inhibits I/R-induced JNK1/2 activation
and apoptosis in HUVECs via enhancing MKP-1 expression.immunoblotting using indicated antibodies. A representative blot was shown. (B)
Quantitative analysis of JNK1/2 phosphorylation, cleaved caspase-3 and PARP was
expressed as fold increase above control group (n = 3, mean ± S.E.M.). (C) HUVECs
were cultured and treated as in A. Cell apoptosis was determined by TUNEL assay.
The number of TUNEL-positive cells was quantiﬁed, and at least 120 cells per dish
were counted (n = 5, means ± S.E.M.). *P < 0.05 vs. control cells, #P < 0.05 vs.
normothermic cells, &P < 0.05 vs. SP600125 plus normothermic cells. N: normo-
thermia; H: hypothermia.4. Discussion
Hypothermia has been reported to protect central neuron, heart
and vascular cells from I/R injury, and clinical application of hypo-
thermia for patients with brain injury and cardiac arrest has been
carried out with promising results [9,18–20]. Recently, systemic
hypothermia was found to improve both survival and neurological
outcome in newborn infants suffering from hypoxic-ischemic
encephalopathy [8]. Although the precise cellular mechanisms
leading to the beneﬁts are unclear, it is noteworthy that hypother-
mia can improve resistance to I/R injury in the myocardium and
neuron through a wide variety of effects, including reduction of
oxygen consumption and metabolic rate [21], inhibition of endo-
thelial cell expression of adhesion molecules and chemokines
[11,22], and alteration of gene expression for mitochondrialproteins and cell death signaling pathways [11,23]. In the present
study, our results showed that hypothermia markedly attenuated
I/R-induced endothelial cell apoptosis by attenuating Fas/cas-
pase-8 activation, reducing Bax/Bcl-2 ratio, and inhibiting JNK1/2
activation. These results indicate that hypothermia protects
against I/R-induced endothelial apoptosis by inactivating extrinsic-
and intrinsic-dependent apoptotic pathways and modulation of
JNK1/2.
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vation of extrinsic (death receptor)- or intrinsic (mitochondrial)-
dependent signaling pathways. The former pathway is triggered
by ligation of death receptors such as Fas and TNFR, resulting in cas-
pase-8 and caspase-3 activation [24]. In contrast to death receptors,
the mitochondrial pathway responds to appropriate apoptotic sig-
nals that regulate the level of Bcl-2 and Bax, whereby the balance
of pro-apoptotic (Bax) and anti-apoptotic (Bcl-2) proteins deter-
mines the relative sensitivity of cells to apoptotic stimuli [24].
Hypothermia has been shown to be an effective treatment against
ischemic injury and apoptosis via inhibition of apoptotic pathways.
In one study of hepatocytes, hypothermia suppressed Fas-mediated
apoptosis and led to less cytochrome c release and activation of cas-
pase-7 and caspase-9 [25]. Recent experiments demonstrated that
hypothermia inhibited I/R-induced oxidative stress and apoptosis
through enhancing the expression of anti-apoptotic Bcl-x and
repressing the expression of p53 in rat cardiomyocytes [11,12].
Consistent with these data in other cells and tissues, the present
study further demonstrated that hypothermia down-regulatedthe expression of caspase-8 cleavage, and Bax/Bcl-2 ratio, thereby
preventing I/R-induced caspase-3 activation and endothelial cell
apoptosis. These results indicate the protective effects of hypother-
mia on I/R-induced endothelial apoptosis through either the
extrinsic death receptor-mediated pathway or the intrinsic mito-
chondrial-dependent pathway.
MAPKs are involved in numerous cellular processes such as pro-
liferation, inﬂammation and apoptosis. Recent data provide evi-
dence that the JNK1/2 and p38 MAPK signaling pathways deliver
an important cell apoptotic signals in several cell lines. JNK1/2 and
p38MAPKwere activated by I/R injury, and their inhibition blocked
I/R-induced apoptosis [4,5,16]. Consistent with these results, our
data indicated that the activation of JNK1/2 was increased after I/R
injury in normothermia, and this effect induced by I/Rwasmarkedly
inhibited by hypothermia or in combination with SP600125.
Furthermore, the inhibition of JNK1/2 by hypothermia was corre-
lated with the decrease in procaspase-3 and PARP cleavage and cell
apoptosis (Fig. 6). These data demonstrate that hypothermia specif-
ically inhibits I/R-induced cell apoptosis in part by blocking activa-
tion of JNK1/2 signaling. Although previous data showed that p38
MAPK signaling played an important role in endothelial cells and
cardiac myocytes during I/R injury, the activation of p38 MAPK by
I/R were not affected markedly by hypothermia in endothelial cells.
Thus, the decrease in JNK1/2 activation by hypothermiamay be part
of its anti-apoptotic effect in HUVECs after I/R, which is also
reﬂected by a decrease in caspases and cell apoptosis.
The exact mechanism of hypothermia-mediated inhibition of
JNK1/2 is not fully understood. However, we postulate that one
possible mechanism is MAPK phosphatase-1 (MKP-1)-mediated
regulation of JNK1/2. Recent studies showed that dual-speciﬁcity
MAPK phosphatases such as MKP-1 preferentially inactivate
JNK1/2 and p38 MAPK, which could not be shown for MKP-2 or
MKP-3 [26–28]. Importantly, MKP-1 has been shown to protect
cells from stress-induced apoptosis in endothelial cells through
inactivation of p38 MAPK and JNK1/2 [26]. Therefore, we propose
that hypothermia may be activating MKP-1, thereby inhibiting
the phosphorylation of JNK1/2 induced by I/R. Indeed, as the pres-
ent study has revealed, the mechanism by which hypothermia
attenuated the activation of JNK1/2 after endothelial I/R, might
very well be through MPK-1 induction (Fig. 7). However, the acti-
vation of MKK4, upstream kinase of JNK1/2 was not affected by
hypothermia (Fig. 7). Thus, our ﬁndings demonstrate that hypo-
thermia inhibits I/R-induced activation of JNK1/2 through MKP-
1-dependent mechanism.
In conclusion, the results of the present study, for the ﬁrst time,
revealed that hypothermia markedly reduced I/R-induced endo-
thelial cell apoptosis via attenuating both extrinsic and intrinsic
pathways, activation of JNK1/2 and enhancing MKP-1 expression.
Our results also suggest that hypothermia can act as an effective
protectant against endothelial I/R injury following cardiac arrest
and stroke. However, further studies are needed to determine the
protective effect of hyperthermia on I/R-induced endothelial apop-
tosis and the underlying mechanisms in vivo animal model.Disclosures
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